Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair

Advanced Drug Delivery Reviews

Volumn 94, Issue , 2015, Pages 53-62

  Agarwal, Rachit ^a,b   García, Andrés J ^a,b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Coatings; Growth factor; Metal implants; Polymer Hydrogel; Therapeutic release

Indexed keywords

BIOACTIVITY; BIOLOGICAL MATERIALS; BONE; CELL ADHESION; CELL SIGNALING; COATINGS; DEFECTS; FUNCTIONAL POLYMERS; HYDROGELS; METALS; REPAIR; TISSUE;

CURRENT TREATMENTS; GROWTH FACTOR; MECHANICAL SUPPORT; MEDICAL COMMUNITY; METAL IMPLANTS; POLYMER HYDROGELS; REVIEW STRATEGIES; THERAPEUTIC RELEASE;

IMPLANTS (SURGICAL);

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; GROWTH FACTOR; HYDROXYAPATITE; INTEGRIN; OSTEOGENIC PROTEIN 1; POLYMER; BMP2 PROTEIN, HUMAN; CYTOKINE; SIGNAL PEPTIDE;

BONE DEFECT; BONE GROWTH; BONE REGENERATION; BONE REMODELING; BONE TISSUE; CELL ADHESION; CELL ENCAPSULATION; CYTOKINE RELEASE; HUMAN; MATERIAL COATING; METAL IMPLANT; NONHUMAN; ORTHOPEDIC IMPLANT; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; REVIEW; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; BONE DEVELOPMENT; BONE IMPLANT INTERFACE; DRUG DELIVERY SYSTEM; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; PROCEDURES; SURFACE PROPERTY; TISSUE SCAFFOLD;

BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; BONE-IMPLANT INTERFACE; CYTOKINES; DRUG DELIVERY SYSTEMS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OSSEOINTEGRATION; OSTEOGENESIS; POLYMERS; SURFACE PROPERTIES; TISSUE SCAFFOLDS;

EID: 84947613023     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2015.03.013     Document Type: Review

References (152)

1. Lee K., Goodman S.B. Current state and future of joint replacements in the hip and knee. Expert Rev. Med. Devices 2008, 5:383-393.
2. Abu-Amer Y., Darwech I., Clohisy J. Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies. Arthritis Res. Ther. 2007, 9:1-7.
3. Bauer T.W., Schils J. The pathology of total joint arthroplasty. Skelet. Radiol. 1999, 28:423-432.
4. Laurencin C., Khan Y., El-Amin S.F. Bone graft substitutes. Expert Rev. Med. Devices 2006, 3:49-57.
5. DeCoster T.A., Gehlert R.J., Mikola E.A., Pirela-Cruz M.A. Management of posttraumatic segmental bone defects. J. Am. Acad. Orthop. Surg. 2004, 12:28-38.
6. Garbuz D.S., Masri B.A., Czitrom A.A. Biology of allografting. Orthop. Clin. N. Am. 1998, 29:199-204.
7. Summers B.N., Eisenstein S.M. Donor site pain from the ilium. A complication of lumbar spine fusion. J. Bone Joint Surg. (Br.) 1989, 71:677-680.
8. Gazdag A.R., Lane J.M., Glaser D., Forster R.A. Alternatives to autogenous bone graft: efficacy and indications. J. Am. Acad. Orthop. Surg. 1995, 3:1-8.
9. McCarthy E.F., Sundaram M. Heterotopic ossification: a review. Skelet. Radiol. 2005, 34:609-619.
10. Ortega N., Behonick D.J., Werb Z. Matrix remodeling during endochondral ossification. Trends Cell Biol. 2004, 14:86-93.
11. Reddi A.H. Cell biology and biochemistry of endochondral bone development. Coll. Relat. Res. 1981, 1:209-226.
12. Mackie E.J., Ahmed Y.A., Tatarczuch L., Chen K.S., Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int. J. Biochem. Cell Biol. 2008, 40:46-62.
13. Schenk R.K., Buser D. Osseointegration: a reality. Periodontology 1998, 2000(17):22-35.
14. Mehta M., Schmidt-Bleek K., Duda G.N., Mooney D.J. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv. Drug Deliv. Rev. 2012, 64:1257-1276.
15. Kumar S., Wan C., Ramaswamy G., Clemens T.L., Ponnazhagan S. Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol. Ther. 2010, 18:1026-1034.
16. Harris J.S., Bemenderfer T.B., Wessel A.R., Kacena M.A. A review of mouse critical size defect models in weight bearing bones. Bone 2013, 55:241-247.
17. Devescovi V., Leonardi E., Ciapetti G., Cenni E. Growth factors in bone repair. Chir. Organi Mov. 2008, 92:161-168.
18. Lieberman J.R., Daluiski A., Einhorn T.A. The Role of Growth Factors in the Repair of Bone 2002.
19. Kitaori T., Ito H., Schwarz E.M., Tsutsumi R., Yoshitomi H., Oishi S., Nakano M., Fujii N., Nagasawa T., Nakamura T. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum. 2009, 60:813-823.
20. Carragee E.J., Hurwitz E.L., Weiner B.K. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011, 11:471-491.
21. Hughes D.E., Salter D.M., Dedhar S., Simpson R. Integrin expression in human bone. J. Bone Miner. Res. 1993, 8:527-533.
22. Inoue T., Hashimoto R., Matsumoto A., Jahan E., Rafiq A.M., Udagawa J., Hatta T., Otani H. In vivo analysis of arg-gly-asp sequence/integrin α5β1-mediated signal involvement in embryonic enchondral ossification by exo utero development system. J. Bone Miner. Res. 2014, 29:1554-1563.
23. Prager-Khoutorsky M., Lichtenstein A., Krishnan R., Rajendran K., Mayo A., Kam Z., Geiger B., Bershadsky A.D. Fibroblast polarization is a matrix-rigidity-dependent process controlled by focal adhesion mechanosensing. Nat. Cell Biol. 2011, 13:1457-1465.
24. Ramazanoglu M., Oshida Y. Osseointegration and Bioscience of Implant Surfaces-Current Concepts at Bone-Implant Interface 2011.
25. Gruskin E., Doll B.A., Futrell F.W., Schmitz J.P., Hollinger J.O. Demineralized bone matrix in bone repair: history and use. Adv. Drug Deliv. Rev. 2012, 64:1063-1077.
26. Ginebra M.P., Canal C., Espanol M., Pastorino D., Montufar E.B. Calcium phosphate cements as drug delivery materials. Adv. Drug Deliv. Rev. 2012, 64:1090-1110.
27. Holt D.J., Grainger D.W. Demineralized bone matrix as a vehicle for delivering endogenous and exogenous therapeutics in bone repair. Adv. Drug Deliv. Rev. 2012, 64:1123-1128.
28. LeGeros R.Z. Calcium phosphate-based osteoinductive materials. Chem. Rev. 2008, 108:4742-4753.
29. Salinas A.J., Vallet-Regi M. Bioactive ceramics: from bone grafts to tissue engineering. RSC Adv. 2013, 3:11116-11131.
30. Lee K., Weir M.D., Lippens E., Mehta M., Wang P., Duda G.N., Kim W.S., Mooney D.J., Xu H.H.K. Bone regeneration via novel macroporous CPC scaffolds in critical-sized cranial defects in rats. Dent. Mater. 2014, 30:e199-e207.
31. Albrektsson T., Hansson H.A., Ivarsson B. Interface analysis of titanium and zirconium bone implants. Biomaterials 1985, 6:97-101.
32. Albrektsson T., Jansson T., Lekholm U. Osseointegrated dental implants. Dent. Clin. N. Am. 1986, 30:151-174.
33. Liu X.-W., Zi Y., Xiang L.-B., Wang Y. Total hip arthroplasty: are view of advances, advantages and limitations. Int. J. Clin. Exp. 2015, 8:27-36.
34. Abu-Amer Y., Darwech I., Clohisy J.C. Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies. Arthritis Res. Ther. 2007, 9(Suppl. 1):S6.
35. Mjoberg B. The theory of early loosening of hip prostheses. Orthopedics 1997, 20:1169-1175.
36. Karrholm J., Borssen B., Lowenhielm G., Snorrason F. Does early micromotion of femoral stem prostheses matter? 4-7-year stereoradiographic follow-up of 84 cemented prostheses. J. Bone Joint Surg. Br. Vol. 1994, 76-B:912-917.
37. Pap T., Claus A., Ohtsu S., Hummel K., Schwartz P., Drynda S., Pap G., Machner A., Stein B., George M., Gay R., Neumann W., Gay S., Aicher W. Osteoclast-independent bone resorption by fibroblast-like cells. Arthritis Res. Ther. 2003, 5:R163-R173.
38. Vale F.M., Castro M., Monteiro J., Couto F.S., Pinto R., Rico J.M.G.T. Acrylic bone cement induces the production of free radicals by cultured human fibroblasts. Biomaterials 1997, 18:1133-1135.
39. Bragdon C.R., Burke D., Lowenstein J.D., O'Connor D.O., Ramamurti B., Jasty M., Harris W.H. Differences in stiffness of the interface between a cementless porous implant and cancellous bone in vivo in dogs due to varying amounts of implant motion. J. Arthroplast 1996, 11:945-951.
40. Maniatopoulos C., Pilliar R.M., Smith D.C. Threaded versus porous-surfaced designs for implant stabilization in bone-endodontic implant model. J. Biomed. Mater. Res. 1986, 20:1309-1333.
41. Anselme K., Bigerelle M. Topography effects of pure titanium substrates on human osteoblast long-term adhesion. Acta Biomater. 2005, 1:211-222.
42. Novaes A.B., de Souza S.L., de Barros R.R., Pereira K.K., Iezzi G., Piattelli A. Influence of implant surfaces on osseointegration. Braz. Dent. J. 2010, 21:471-481.
43. Schwartz Z., Lohmann C.H., Oefinger J., Bonewald L.F., Dean D.D., Boyan B.D. Implant surface characteristics modulate differentiation behavior of cells in the osteoblastic lineage. Adv. Dent. Res. 1999, 13:38-48.
44. Boyan B.D., Sylvia V.L., Liu Y., Sagun R., Cochran D.L., Lohmann C.H., Dean D.D., Schwartz Z. Surface roughness mediates its effects on osteoblasts via protein kinase A and phospholipase A2. Biomaterials 1999, 20:2305-2310.
45. Olivares-Navarrete R., Raz P., Zhao G., Chen J., Wieland M., Cochran D.L., Chaudhri R.A., Ornoy A., Boyan B.D., Schwartz Z. Integrin α2β1 plays a critical role in osteoblast response to micron-scale surface structure and surface energy of titanium substrates. Proc. Natl. Acad. Sci. 2008, 105:15767-15772.
46. Klokkevold P.R., Johnson P., Dadgostari S., Davies J.E., Caputo A., Nishimura R.D. Early endosseous integration enhanced by dual acid etching of titanium: a torque removal study in the rabbit. Clin. Oral Implants Res. 2001, 12:350-357.
47. Wennerberg A., Albrektsson T. Suggested guidelines for the topographic evaluation of implant surfaces. Int. J. Oral Maxillofac. Implants 2000, 15:331-344.
48. Shalabi M.M., Gortemaker A., Hof M.A.V.t., Jansen J.A., Creugers N.H.J. Implant surface roughness and bone healing: a systematic review. J. Dent. Res. 2006, 85:496-500.
49. Rupp F., Scheideler L., Olshanska N., de Wild M., Wieland M., Geis-Gerstorfer J. Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces. J. Biomed. Mater. Res. A 2006, 76A:323-334.
50. Sul Y.-T., Johansson C.B., Jeong Y., Wennerberg A., Albrektsson T. Resonance frequency and removal torque analysis of implants with turned and anodized surface oxides. Clin. Oral Implants Res. 2002, 13:252-259.
51. Keselowsky B.G., Collard D.M., Garcia A.J. Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion. J. Biomed. Mater. Res. A 2003, 66:247-259.
52. Keselowsky B.G., Collard D.M., Garcia A.J. Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5953-5957.
53. Soballe K. Hydroxyapatite ceramic coating for bone implant fixation. Mechanical and histological studies in dogs. Acta Orthop. Scand. Suppl. 1993, 255:1-58.
54. Cook S.D., Thomas K.A., Dalton J.E., Volkman T.K., Whitecloud T.S., Kay J.F. Hydroxylapatite coating of porous implants improves bone ingrowth and interface attachment strength. J. Biomed. Mater. Res. 1992, 26:989-1001.
55. Barrère F., van der Valk C.M., Meijer G., Dalmeijer R.A.J., de Groot K., Layrolle P. Osteointegration of biomimetic apatite coating applied onto dense and porous metal implants in femurs of goats. J. Biomed. Mater. Res. B Appl. Biomater. 2003, 67B:655-665.
56. Lindner T., Kanakaris N.K., Marx B., Cockbain A., Kontakis G., Giannoudis P.V. Fractures of the hip and osteoporosis: the role of bone substitutes. J. Bone Joint Surg. Br. Vol. 2009, 91-B:294-303.
57. Moroni A., Hoang-Kim A., Lio V., Giannini S. Current augmentation fixation techniques for the osteoporotic patient. Scand. J. Surg. 2006, 95:103-109.
58. Valentin M.I. Coatings based on calcium phosphates for metallic medical implants. Russ. Chem. Rev. 2013, 82:131.
59. Elyada A., Garti N., Furedi-Milhofer H. Polyelectrolyte multilayer-calcium phosphate composite coatings for metal implants. Biomacromolecules 2014, 15:3511-3521.
60. de Groot K., Wolke J.G., Jansen J.A. Calcium phosphate coatings for medical implants. Proc. Inst. Mech. Eng. H J. Eng. Med. 1998, 212:137-147.
61. Rezania A., Thomas C.H., Branger A.B., Waters C.M., Healy K.E. The detachment strength and morphology of bone cells contacting materials modified with a peptide sequence found within bone sialoprotein. J. Biomed. Mater. Res. 1997, 37:9-19.
62. Rezania A., Healy K.E. Biomimetic peptide surfaces that regulate adhesion, spreading, cytoskeletal organization, and mineralization of the matrix deposited by osteoblast-like cells. Biotechnol. Prog. 1999, 15:19-32.
63. Martino M.M., Mochizuki M., Rothenfluh D.A., Rempel S.A., Hubbell J.A., Barker T.H. Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials 2009, 30:1089-1097.
64. Petrie T.A., Reyes C.D., Burns K.L., Garcia A.J. Simple application of fibronectin-mimetic coating enhances osseointegration of titanium implants. J. Cell. Mol. Med. 2009, 13:2602-2612.
65. Kariolis M.S., Kapur S., Cochran J.R. Beyond antibodies: using biological principles to guide the development of next-generation protein therapeutics. Curr. Opin. Biotechnol. 2013, 24:1072-1077.
66. Trajkovski B., Petersen A., Strube P., Mehta M., Duda G.N. Intra-operatively customized implant coating strategies for local and controlled drug delivery to bone. Adv. Drug Deliv. Rev. 2012, 64:1142-1151.
67. Ferris D.M., Moodie G.D., Dimond P.M., Giorani C.W.D., Ehrlich M.G., Valentini R.F. RGD-coated titanium implants stimulate increased bone formation in vivo. Biomaterials 1999, 20:2323-2331.
68. García A.J. Get a grip: integrins in cell-biomaterial interactions. Biomaterials 2005, 26:7525-7529.
69. Schliephake H., Scharnweber D., Dard M., Rößler S., Sewing A., Meyer J., Hoogestraat D. Effect of RGD peptide coating of titanium implants on periimplant bone formation in the alveolar crest. Clin. Oral Implants Res. 2002, 13:312-319.
70. Hennessy K.M., Clem W.C., Phipps M.C., Sawyer A.A., Shaikh F.M., Bellis S.L. The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials. Biomaterials 2008, 29:3075-3083.
71. Barber T.A., Ho J.E., De Ranieri A., Virdi A.S., Sumner D.R., Healy K.E. Peri-implant bone formation and implant integration strength of peptide-modified p(AAM-co-EG/AAC) interpenetrating polymer network-coated titanium implants. J. Biomed. Mater. Res. A 2007, 80A:306-320.
72. Reyes C.D., Garcia A.J. Engineering integrin-specific surfaces with a triple-helical collagen-mimetic peptide. J. Biomed. Mater. Res. A 2003, 65:511-523.
73. Reyes C.D., Petrie T.A., Burns K.L., Schwartz Z., Garcia A.J. Biomolecular surface coating to enhance orthopaedic tissue healing and integration. Biomaterials 2007, 28:3228-3235.
74. Petrie T.A., Raynor J.E., Reyes C.D., Burns K.L., Collard D.M., Garcia A.J. The effect of integrin-specific bioactive coatings on tissue healing and implant osseointegration. Biomaterials 2008, 29:2849-2857.
75. Petrie T.A., Raynor J.E., Dumbauld D.W., Lee T.T., Jagtap S., Templeman K.L., Collard D.M., Garcia A.J. Multivalent integrin-specific ligands enhance tissue healing and biomaterial integration. Sci. Transl. Med. 2010, 2:45ra60.
76. Thorey F., Menzel H., Lorenz C., Gross G., Hoffmann A., Windhagen H. Osseointegration by bone morphogenetic protein-2 and transforming growth factor beta2 coated titanium implants in femora of New Zealand white rabbits. Indian J. Orthop. 2011, 45:57-62.
77. Ramazanoglu M., Lutz R., Rusche P., Trabzon L., Kose G.T., Prechtl C., Schlegel K.A. Bone response to biomimetic implants delivering BMP-2 and VEGF: An immunohistochemical study. J. Craniomaxillofacial Surg 2013, 41:826-835.
78. Kashiwagi K., Tsuji T., Shiba K. Directional BMP-2 for functionalization of titanium surfaces. Biomaterials 2009, 30:1166-1175.
79. Yuasa K., Kokubu E., Kokubun K., Matsuzaka K., Shiba K., Kashiwagi K., Inoue T. An artificial fusion protein between bone morphogenetic protein 2 and titanium-binding peptide is functional in vivo. J. Biomed. Mater. Res. A 2014, 102:1180-1186.
80. Ceylan H., Kocabey S., Tekinay A.B., Guler M.O. Surface-adhesive and osteogenic self-assembled peptide nanofibers for bioinspired functionalization of titanium surfaces. Soft Matter 2012, 8:3929-3937.
81. Lu Y., Lee J.S., Nemke B., Graf B.K., Royalty K., Illgen R., Vanderby R., Markel M.D., Murphy W.L. Coating with a modular bone morphogenetic peptide promotes healing of a bone-implant gap in an ovine model. PLoS ONE 2012, 7:e50378.
82. Tengvall P., Skoglund B., Askendal A., Aspenberg P. Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats. Biomaterials 2004, 25:2133-2138.
83. Skoglund B., Holmertz J., Aspenberg P. Systemic and local ibandronate enhance screw fixation. J. Orthop. Res. 2004, 22:1108-1113.
84. Wermelin K., Tengvall P., Aspenberg P. Surface-bound bisphosphonates enhance screw fixation in rats-increasing effect up to 8weeks after insertion. Acta Orthop. 2007, 78:385-392.
85. Andersson T., Agholme F., Aspenberg P., Tengvall P. Surface immobilized zoledronate improves screw fixation in rat bone: a new method for the coating of metal implants. J. Mater. Sci. Mater. Med. 2010, 21:3029-3037.
86. Wermelin K., Suska F., Tengvall P., Thomsen P., Aspenberg P. Stainless steel screws coated with bisphosphonates gave stronger fixation and more surrounding bone. Histomorphometry in rats. Bone 2008, 42:365-371.
87. Wermelin K., Aspenberg P., Linderbäck P., Tengvall P. Bisphosphonate coating on titanium screws increases mechanical fixation in rat tibia after two weeks. J. Biomed. Mater. Res. A 2008, 86A:220-227.
88. Abtahi J., Tengvall P., Aspenberg P. A bisphosphonate-coating improves the fixation of metal implants in human bone. A randomized trial of dental implants. Bone 2012, 50:1148-1151.
89. Macdonald M.L., Samuel R.E., Shah N.J., Padera R.F., Beben Y.M., Hammond P.T. Tissue integration of growth factor-eluting layer-by-layer polyelectrolyte multilayer coated implants. Biomaterials 2011, 32:1446-1453.
90. Shah N.J., Hyder M.N., Moskowitz J.S., Quadir M.A., Morton S.W., Seeherman H.J., Padera R.F., Spector M., Hammond P.T. Surface-mediated bone tissue morphogenesis from tunable nanolayered implant coatings. Sci. Transl. Med. 2013, 5:191ra183.
91. Song W., Yu X., Markel D.C., Shi T., Ren W. Coaxial PCL/PVA electrospun nanofibers: osseointegration enhancer and controlled drug release device. Biofabrication 2013, 5:035006.
92. Choi J., Konno T., Takai M., Ishihara K. Controlled drug release from multilayered phospholipid polymer hydrogel on titanium alloy surface. Biomaterials 2009, 30:5201-5208.
93. Pauly S., Luttosch F., Morawski M., Haas N.P., Schmidmaier G., Wildemann B. Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application. Bone 2009, 45:505-511.
94. Hickok N.J., Shapiro I.M. Immobilized antibiotics to prevent orthopaedic implant infections. Adv. Drug Deliv. Rev. 2012, 64:1165-1176.
95. Boerckel J.D., Kolambkar Y.M., Dupont K.M., Uhrig B.A., Phelps E.A., Stevens H.Y., García A.J., Guldberg R.E. Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 2011, 32:5241-5251.
96. Aspenberg P. Bone: silk, metal and bone: why take implants out?. Nat. Rev. Rheumatol. 2014, 10:386-387.
97. Liao J.-C., Niu C.-C., Chen W.-J., Chen L.-H. Polyetheretherketone (PEEK) cage filled with cancellous allograft in anterior cervical discectomy and fusion. Int. Orthop. SICO 2008, 32:643-648.
98. Kurtz S.M., Devine J.N. PEEK biomaterials in trauma, orthopedic, and spinal implants. Biomaterials 2007, 28:4845-4869.
99. Toth J.M., Wang M., Estes B.T., Scifert J.L., Seim Iii H.B., Turner A.S. Polyetheretherketone as a biomaterial for spinal applications. Biomaterials 2006, 27:324-334.
100. Eppley B.L. Use of resorbable plates and screws in pediatric facial fractures. J. Oral Maxillofac. Surg 2005, 63:385-391.
101. Böstman O.M. Absorbable implants for the fixation of fractures. J. Bone Joint Surg. 1991, 73:148-153.
102. Dumont C., Fuchs M., Burchhardt H., Appelt D., Bohr S., Stürmer K.M. Clinical Results of Absorbable Plates for Displaced Metacarpal Fractures. J. Hand Surg 2007, 32:491-496.
103. Zhang J., Ebraheim N., Lausé G.E., Xiao B., Xu R. A comparison of absorbable screws and metallic plates in treating calcaneal fractures: a prospective randomized trial. J. Trauma Acute Care Surg. 2012, 72:E106-E110. 10.1097/TA.1090b1013e3182231811.
104. Böstman O.M., Laitinen O.M., Tynninen O., Salminen S.T., Pihlajamäki H.K. Tissue restoration after resorption of polyglycolide and poly-laevo-lactic acid screws. J. Bone Joint Surg. Br. Vol. 2005, 87-B:1575-1580.
105. Perrone G.S., Leisk G.G., Lo T.J., Moreau J.E., Haas D.S., Papenburg B.J., Golden E.B., Partlow B.P., Fox S.E., Ibrahim A.M.S., Lin S.J., Kaplan D.L. The use of silk-based devices for fracture fixation. Nat. Commun. 2014, 5.
106. Jager M., Hernigou P., Zilkens C., Herten M., Li X., Fischer J., Krauspe R. Cell therapy in bone healing disorders. Orthop. Rev. 2010, 2:e20.
107. Kim S.-J., Shin Y.-W., Yang K.-H., Kim S.-B., Yoo M.-J., Han S.-K., Im S.-A., Won Y.-D., Sung Y.-B., Jeon T.-S., Chang C.-H., Jang J.-D., Lee S.-B., Kim H.-C., Lee S.-Y. A multi-center, randomized, clinical study to compare the effect and safety of autologous cultured osteoblast(OssronTM) injection to treat fractures. BMC Musculoskelet. Disord. 2009, 10:20.
108. Mooney D.J., Vandenburgh H. Cell delivery mechanisms for tissue repair. Cell Stem Cell 2008, 2:205-213.
109. Guldberg R.E. Spatiotemporal delivery strategies for promoting musculoskeletal tissue regeneration. J. Bone Miner. Res. 2009, 24:1507-1511.
110. Mizuno M., Shindo M., Kobayashi D., Tsuruga E., Amemiya A., Kuboki Y. Osteogenesis by bone marrow stromal cells maintained on type I collagen matrix gels in vivo. Bone 1997, 20:101-107.
111. Solchaga L.A., Dennis J.E., Goldberg V.M., Caplan A.I. Hyaluronic acid-based polymers as cell carriers for tissue-engineered repair of bone and cartilage. J. Orthop. Res. 1999, 17:205-213.
112. Swetha M., Sahithi K., Moorthi A., Srinivasan N., Ramasamy K., Selvamurugan N. Biocomposites containing natural polymers and hydroxyapatite for bone tissue engineering. Int. J. Biol. Macromol. 2010, 47:1-4.
113. Stevens M.M. Biomaterials for bone tissue engineering. Mater. Today 2008, 11:18-25.
114. Hanes J., Chiba M., Langer R. Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery. Biomaterials 1998, 19:163-172.
115. Ibim S.M., Uhrich K.E., Bronson R., El-Amin S.F., Langer R.S., Laurencin C.T. Poly(anhydride-co-imides): in vivo biocompatibility in a rat model. Biomaterials 1998, 19:941-951.
116. Uhrich K.E., Gupta A., Thomas T.T., Laurencin C.T., Langer R. Synthesis and characterization of degradable poly(anhydride-co-imides). Macromolecules 1995, 28:2184-2193.
117. Choueka J., Charvet J.L., Koval K.J., Alexander H., James K.S., Hooper K.A., Kohn J. Canine bone response to tyrosine-derived polycarbonates and poly(L-lactic acid). J. Biomed. Mater. Res. 1996, 31:35-41.
118. Peter S.J., Yaszemski M.J., Suggs L.J., Payne R.G., Langer R., Hayes W.C., Unroe M.R., Alemany L.B., Engel P.S., Mikos A.G. Characterization of partially saturated poly(propylene fumarate) for orthopaedic application. J. Biomater. Sci. Polym. Ed. 1997, 8:893-904.
119. Yaszemski M.J., Payne R.G., Hayes W.C., Langer R.S., Aufdemorte T.B., Mikos A.G. The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold. Tissue Eng. 1995, 1:41-52.
120. Deschamps A.A., Claase M.B., Sleijster W.J., de Bruijn J.D., Grijpma D.W., Feijen J. Design of segmented poly(ether ester) materials and structures for the tissue engineering of bone. J. Control. Release 2002, 78:175-186.
121. Mariner P.D., Wudel J.M., Miller D.E., Genova E.E., Streubel S.-O., Anseth K.S. Synthetic hydrogel scaffold is an effective vehicle for delivery of INFUSE (rhBMP2) to critical-sized calvaria bone defects in rats. J. Orthop. Res. 2013, 31:401-406.
122. Santo V.E., Frias A.M., Carida M., Cancedda R., Gomes M.E., Mano J.F., Reis R.L. Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications. Biomacromolecules 2009, 10:1392-1401.
123. Chen F.-M., Chen R., Wang X.-J., Sun H.-H., Wu Z.-F. In vitro cellular responses to scaffolds containing two microencapulated growth factors. Biomaterials 2009, 30:5215-5224.
124. Patel Z.S., Young S., Tabata Y., Jansen J.A., Wong M.E.K., Mikos A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008, 43:931-940.
125. Yilgor P., Hasirci N., Hasirci V. Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. J. Biomed. Mater. Res. A 2010, 93A:528-536.
126. Yilgor P., Tuzlakoglu K., Reis R.L., Hasirci N., Hasirci V. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials 2009, 30:3551-3559.
127. Kimelman N., Pelled G., Helm G.A., Huard J., Schwarz E.M., Gazit D. Review: gene- and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng. 2007, 13:1135-1150.
128. Hutmacher D.W., Garcia A.J. Scaffold-based bone engineering by using genetically modified cells. Gene 2005, 347:1-10.
129. Prockop D.J., Kota D.J., Bazhanov N., Reger R.L. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J. Cell. Mol. Med. 2010, 14:2190-2199.
130. Caplan A.I. New era of cell-based orthopedic therapies. Tissue Eng. B Rev. 2009, 15:195-200.
131. Ohgushi H., Goldberg V.M., Caplan A.I. Repair of bone defects with marrow cells and porous ceramic. Experiments in rats. Acta Orthop. Scand. 1989, 60:334-339.
132. Horwitz E.M., Prockop D.J., Gordon P.L., Koo W.W.K., Fitzpatrick L.A., Neel M.D., McCarville M.E., Orchard P.J., Pyeritz R.E., Brenner M.K. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta 2001.
133. Bongso A., Fong C.-Y., Gauthaman K. Taking stem cells to the clinic: major challenges. J. Cell. Biochem. 2008, 105:1352-1360.
134. Sonnet C., Simpson C.L., Olabisi R.M., Sullivan K., Lazard Z., Gugala Z., Peroni J.F., Weh J.M., Davis A.R., West J.L., Olmsted-Davis E.A. Rapid healing of femoral defects in rats with low dose sustained BMP2 expression from PEGDA hydrogel microspheres. J. Orthop. Res. 2013, 31:1597-1604.
135. Huang Y.-C., Kaigler D., Rice K.G., Krebsbach P.H., Mooney D.J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J. Bone Miner. Res. 2005, 20:848-857.
136. Reichert J.C., Cipitria A., Epari D.R., Saifzadeh S., Krishnakanth P., Berner A., Woodruff M.A., Schell H., Mehta M., Schuetz M.A., Duda G.N., Hutmacher D.W. A tissue engineering solution for segmental defect regeneration in load-bearing long bones. Sci. Transl. Med. 2012, 4:141ra193.
137. Wojtowicz A.M., Templeman K.L., Hutmacher D.W., Guldberg R.E., Garcia A.J. Runx2 overexpression in bone marrow stromal cells accelerates bone formation in critical-sized femoral defects. Tissue Eng. A 2010, 16:2795-2808.
138. Kaigler D., Krebsbach P.H., West E.R., Horger K., Huang Y.-C., Mooney D.J. Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J. 2005, 19:665-667.
139. Gandavarapu N.R., Mariner P.D., Schwartz M.P., Anseth K.S. Extracellular matrix protein adsorption to phosphate-functionalized gels from serum promotes osteogenic differentiation of human mesenchymal stem cells. Acta Biomater. 2013, 9:4525-4534.
140. Alsberg E., Anderson K.W., Albeiruti A., Rowley J.A., Mooney D.J. Engineering growing tissues. Proc. Natl. Acad. Sci. 2002, 99:12025-12030.
141. Hsu C.-W., Olabisi R.M., Olmsted-Davis E.A., Davis A.R., West J.L. Cathepsin K-sensitive poly(ethylene glycol) hydrogels for degradation in response to bone resorption. J. Biomed. Mater. Res. A 2011, 98A:53-62.
142. Lutolf M.P., Weber F.E., Schmoekel H.G., Schense J.C., Kohler T., Muller R., Hubbell J.A. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat. Biotechnol. 2003, 21:513-518.
143. Wojtowicz A.M., Shekaran A., Oest M.E., Dupont K.M., Templeman K.L., Hutmacher D.W., Guldberg R.E., Garcia A.J. Coating of biomaterial scaffolds with the collagen-mimetic peptide GFOGER for bone defect repair. Biomaterials 2010, 31:2574-2582.
144. Shekaran A., García J.R., Clark A.Y., Kavanaugh T.E., Lin A.S., Guldberg R.E., García A.J. Bone regeneration using an alpha 2 beta 1 integrin-specific hydrogel as a BMP-2 delivery vehicle. Biomaterials 2014, 35:5453-5461.
145. Martino M.M., Tortelli F., Mochizuki M., Traub S., Ben-David D., Kuhn G.A., Muller R., Livne E., Eming S.A., Hubbell J.A. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci. Transl. Med. 2011, 3:100ra189.
146. Lu H., Kawazoe N., Kitajima T., Myoken Y., Tomita M., Umezawa A., Chen G., Ito Y. Spatial immobilization of bone morphogenetic protein-4 in a collagen-PLGA hybrid scaffold for enhanced osteoinductivity. Biomaterials 2012, 33:6140-6146.
147. Garrison K.R., Donell S., Ryder J., Shemilt I., Mugford M., Harvey I., Song F. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technol. Assess. 2007, 11:1-150. (iii-iv).
148. Martino M.M., Hubbell J.A. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J. 2010, 24:4711-4721.
149. Martino M.M., Briquez P.S., Guc E., Tortelli F., Kilarski W.W., Metzger S., Rice J.J., Kuhn G.A., Muller R., Swartz M.A., Hubbell J.A. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science 2014, 343:885-888.
150. Wang Y., Grainger D.W. RNA therapeutics targeting osteoclast-mediated excessive bone resorption. Adv. Drug Deliv. Rev. 2012, 64:1341-1357.
151. Evans C.H. Gene delivery to bone. Adv. Drug Deliv. Rev. 2012, 64:1331-1340.
152. Suárez-González D., Barnhart K., Migneco F., Flanagan C., Hollister S.J., Murphy W.L. Controllable mineral coatings on PCL scaffolds as carriers for growth factor release. Biomaterials 2012, 33:713-721.